Literature DB >> 4723802

Effect of chronic L-DOPA administration of catecholamine metabolism in the rat.

J Lancaster, P R Sawyer, D M Shepherd, M J Turnbull.   

Abstract

1. L-DOPA was administered to rats by twice daily intraperitoneal injection for a period of eleven days. The daily dose was gradually increased from 250 mg/kg to 1 g/kg. The animals were killed 12 h after the last injection and tissue catechol-O-methyl transferase, DOPA-decarboxylase and monoamine oxidase activity determined.2. Catechol-O-methyl transferase activity was reduced in the liver (46%) and red blood cells (38%) but was approximately doubled in the heart.3. Liver DOPA-decarboxylase activity was reduced by approximately 25%.4. L-DOPA administration did not significantly affect the activity of any of the enzymes studied in brain tissue.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4723802      PMCID: PMC1776083          DOI: 10.1111/j.1476-5381.1973.tb08211.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Aromatic L-amino acid decarboxylase.

Authors:  W LOVENBERG; H WEISSBACH; S UDENFRIEND
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Serum-monoamine-oxidase levels during levodopa therapy.

Authors:  N Tryding; G Tufvesson; S Nilsson
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

4.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

Review 5.  Assay of enzymes of catecholamine biosynthesis and metabolism.

Authors:  C R Creveling; J W Daly
Journal:  Methods Biochem Anal       Date:  1971

6.  Comment on microfluorometric determination of monoamine oxidase.

Authors:  B Century; K L Rupp
Journal:  Biochem Pharmacol       Date:  1968-09       Impact factor: 5.858

7.  Decrease in adrenal tyrosine hydroxylase and increase in norepinephrine synthesis in rats given L-dopa.

Authors:  W Dairman; S Udenfriend
Journal:  Science       Date:  1971-03-12       Impact factor: 47.728

8.  Reduction of catechol-O-methyl-transferases activity by chronic L-dopa therapy.

Authors:  J L Weiss; C K Cohn; T N Chase
Journal:  Nature       Date:  1971-11-26       Impact factor: 49.962

  8 in total
  3 in total

1.  Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.

Authors:  Zhaofei Yang; Xuan Wang; Jian Yang; Min Sun; Yong Wang; Xiaomin Wang
Journal:  Neurotox Res       Date:  2016-12-15       Impact factor: 3.911

2.  L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.

Authors:  Jennifer M King; Gladson Muthian; Veronica Mackey; Marquitta Smith; Clivel Charlton
Journal:  Life Sci       Date:  2011-08-18       Impact factor: 5.037

3.  Chronic L-DOPA treatment of mice: a behavioural and biochemical study.

Authors:  R Bailey; E Crisp; D M Jackson; O Jenkins
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.